… of coronavirus disease 2019 (COVID-19) disease severity and extrapulmonary complications
(… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNAemia and disease severity, …

… between RNAemia and severe COVID-19 and support the presence of RNA in extrapulmonary
… detection of SARS-CoV-1 RNA in serum and clinical complications including oxygen …

… SARS-CoV-2 RNAemia is associated with worse quality of life and the presence of more
long-COVID … The risk factors for long-COVID defined in our study may help identify patients who …

… surpasses the epithelial barrier and disseminates through the bloodstream, reaching
extrapulmonary sites 2 . Supporting this view, apparently intact virions have been identified in …

… rate in SARS-CoV-2 RNAemia cases (p < 0.001). Conclusions: Our study demonstrated
that SARS-CoV-2 RNAemia is a predictive risk factor for clinical severity in COVID-19 patients. …

… RNAemia, antibody response against SARS-CoV-2, and proteomic profiles in serial blood
samples from COVID-19 patients admitted to two … (pulmonary and extrapulmonary) 25,26 and …

… 4a, the CT score was inversely correlated with the SARS-CoV-2 viral load in nasal-swab …
with RNAemia than in those without RNAemia (Fig. 4b). Since the PCR results for RNAemia …

… The pathogenesis of these extrarespiratory complications is not fully understood, … SARS
CoV-2 RNAemia and associated systemic inflammatory response during the course of COVID-19…

… with PCR verified COVID-19 admitted to ICU. SARS-CoV-2 RNAemia (hereafter RNAemia)
in … Although RNAemia was not associated with extra pulmonary organ failure, patients with …

… of severe COVID-19, extrapulmonary pathologies have also been consistently reported [19,96]
(Figure … Long-term complications are not unexpected given the broader organotropism of …